The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.41BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Trailing P/E
47.36x
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Revenue (TTM)
2.86BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Profit Margin
3.33%
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Beta
0.8610x
vs all stocks
Updated Aug 28, 2026
52-Week Change
29.56%
vs all stocks
Updated Aug 28, 2026
Market Capitalization
4.41BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Enterprise Value
4.87BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Trailing P/E
47.36x
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Forward P/E
16.47x
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
PEG Ratio
0.4458x
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Price to Sales (TTM)
1.54x
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Price to Book (MRQ)
1.43x
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Enterprise to Revenue
1.71x
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Enterprise to EBITDA
12.00x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 10.97×.Updated Aug 28, 2026
Gross Margin
55.72%
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Profit Margin
3.33%
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Operating Margin
10.39%
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Return on Assets (TTM)
3.23%
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Return on Equity (TTM)
3.06%
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Revenue (TTM)
2.86BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Revenue per Share (TTM)
17.41USDUpdated Aug 28, 2026
Quarterly Revenue Growth
7.10%
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Gross Profit (TTM)
1.58BUSD
vs all stocks (USD)
Updated Aug 28, 2026
EBITDA (TTM)
444.20MUSD
vs all stocks (USD)
Updated Aug 28, 2026
Net Income (TTM)
95.00MUSD
vs all stocks (USD)
Updated Aug 28, 2026
Quarterly Earnings Growth (YoY)
103.40%
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Operating Cash Flow (TTM)
302.60MUSD
vs all stocks (USD)
Updated Aug 28, 2026
Levered Free Cash Flow (TTM)
267.89MUSD
vs all stocks (USD)
Updated Aug 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Aug 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Aug 28, 2026
Payout Ratio
0.00%
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Revenue
2.72BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
1.23BUSDFY2025 · Dec 31, 2025
Gross Profit
1.49BUSDFY2025 · Dec 31, 2025
Operating Income
235.80MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
177.20MUSDFY2025 · Dec 31, 2025
Income Tax Expense
130.20MUSDFY2025 · Dec 31, 2025
Net Income
47.00MUSDFY2025 · Dec 31, 2025
EBIT
213.80MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
384.20MUSDFY2025 · Dec 31, 2025
Research & Development
114.00MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
1.14BUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
36.60MUSDFY2025 · Dec 31, 2025
Net Income from Continuing Operations
47.00MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
136.10MUSDFY2025 · Dec 31, 2025
Free Cash Flow
91.30MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.21BUSDFY2025 · Dec 31, 2025
Income Tax Paid
79.80MUSDFY2025 · Dec 31, 2025
Interest Paid
46.10MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
47.00MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
150.70MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
11.40MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
37.60MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
4.20MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-48.50MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
7.50MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-73.80MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-44.80MUSDFY2025 · Dec 31, 2025
Net Acquisitions
0.00USDFY2025 · Dec 31, 2025
Purchase of Investments
-9.90MUSDFY2025 · Dec 31, 2025
Sale of Investments
10.40MUSDFY2025 · Dec 31, 2025
Other Investing Activity
-6.80MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-51.10MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-116.30MUSDFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
115.40MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-166.60MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-6.20MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-173.70MUSDFY2025 · Dec 31, 2025
Shares Outstanding
160.60MSharesUpdated Aug 28, 2026
Float Shares
159.89MSharesUpdated Aug 28, 2026
Shares Short
9.63MSharesUpdated Aug 28, 2026
Short Ratio
3.23days
vs all stocks
Updated Aug 28, 2026
Short % of Shares Outstanding
6.73%
vs all stocks
Updated Aug 28, 2026
% Held by Insiders
0.50%
vs all stocks
Updated Aug 28, 2026
% Held by Institutions
120.96%
vs all stocks
Updated Aug 28, 2026
Total Cash (MRQ)
1.13BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Total Cash per Share (MRQ)
7.01USDUpdated Aug 28, 2026
Total Debt (MRQ)
1.59BUSD
vs all stocks (USD)
Updated Aug 28, 2026
Total Debt to Equity (MRQ)
0.5162x
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Current Ratio (MRQ)
2.42x
vs Medical Instruments & Supplies peers
Updated Aug 28, 2026
Book Value per Share (MRQ)
19.16USDUpdated Aug 28, 2026
Total Assets
5.68BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.03BUSDFY2025 · Dec 31, 2025
Total Liabilities
2.57BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
3.65BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.72BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
852.60MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.21BUSDFY2025 · Dec 31, 2025
Accounts Receivable
429.60MUSDFY2025 · Dec 31, 2025
Inventory
288.10MUSDFY2025 · Dec 31, 2025
Accounts Payable
191.60MUSDFY2025 · Dec 31, 2025
Short-term Debt
39.00MUSDFY2025 · Dec 31, 2025
Deferred Revenue
184.80MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
97.60MUSDFY2025 · Dec 31, 2025
Long-term Debt
1.56BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
12.00MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
1.80MUSDFY2025 · Dec 31, 2025
Retained Earnings
-440.40MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.11BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
224.50MUSDFY2025 · Dec 31, 2025
52-Week Low
18.77USDUpdated Aug 28, 2026
52-Week High
30.42USDUpdated Aug 28, 2026
52-Week Change
29.56%
vs all stocks
Updated Aug 28, 2026
Beta
0.8610x
vs all stocks
Updated Aug 28, 2026
50-Day MA
26.87USDUpdated Aug 28, 2026
200-Day MA
24.96USDUpdated Aug 28, 2026
Avg 10-Day Volume
2.48MSharesUpdated Aug 28, 2026
Avg 30-Day Volume
2.88MSharesUpdated Aug 28, 2026
Diluted EPS (TTM)
0.5800USDUpdated Aug 28, 2026
Other Income / Expense
-22.00MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
More cash comes in than it reports as profit, little goes back out on equipment, and much of the gap is depreciation.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.56Profit Margin: 0.03
Financial Health
Altman Z-Score 1.77: grey zoneSignificant
Altman Z-Score: 1.77
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $4.41B, above the global median of $1.18BNotable
Market cap (USD): 4,407,349,934Global Median: 1,179,398,897.704
Revenue is $2.86B, above the global median of $534.05MNotable